Sensei Biotherapeutics (NASDAQ:SNSE) Issues Earnings Results, Meets Expectations

Sensei Biotherapeutics (NASDAQ:SNSE) posted its quarterly earnings results on Friday. The company reported ($0.27) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.27), Zacks reports.

Sensei Biotherapeutics Stock Performance

Sensei Biotherapeutics stock opened at $0.51 on Friday. Sensei Biotherapeutics has a 52 week low of $0.38 and a 52 week high of $1.94. The firm has a market capitalization of $12.78 million, a PE ratio of -0.43 and a beta of 0.16. The business’s 50-day simple moving average is $0.47 and its 200-day simple moving average is $0.49.

Analysts Set New Price Targets

A number of equities analysts recently issued reports on SNSE shares. Oppenheimer lifted their target price on Sensei Biotherapeutics from $3.50 to $4.00 and gave the stock an “outperform” rating in a report on Friday. HC Wainwright reissued a “buy” rating and set a $4.00 target price on shares of Sensei Biotherapeutics in a research note on Friday.

Sensei Biotherapeutics Company Profile

Sensei Biotherapeutics, Inc, an immuno-oncology company, engages in the discovery and development of therapeutics for cancer patients. The company's Tumor Microenvironment Activated Biologics platform is designed to generate highly selective therapeutics that disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment.